Home › NDC Lookup › RxCUI directory › RxCUI 104062

Cimetidine 200 MG Oral Tablet [Tagamet] — RxCUI 104062

RxNorm drug concept · Semantic branded drug
RxCUI 104062 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI104062
Official nameCimetidine 200 MG Oral Tablet [Tagamet]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTagamet 200 MG Oral Tablet; Tagamet HB 200 MG Oral Tablet
FDA products mapped3
Package NDCs mapped12
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cimetidine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The over-the-counter tablets — brands like Acid Reducer, Equate Cimetidine, and Basic Care Acid Reducer — are intended for everyday heartburn relief and prevention. You take one ta...
  • What's the difference between the OTC cimetidine tablets and the prescription version?
  • It's actually best not to take them at the exact same time. Antacids can interfere with how well cimetidine is absorbed from your stomach, which means the cimetidine may not work a...
  • Can I take antacids at the same time as cimetidine?
📖 Read our full Cimetidine guide →

🕸️ Concept Web — How Cimetidine 200 MG Oral Tablet [Tagamet] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cimetidine 200 MG Oral Tablet [Tagamet] RxCUI 104062

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cimetidine 2541
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tagamet 152402
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cimetidine Oral Tablet 371515
    • Cimetidine Oral Product 1151784
    • Cimetidine Pill 1151785
    • Cimetidine Oral Tablet [Tagamet] 94235
    • Tagamet Oral Product 1177838
    • Tagamet Pill 1177839
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cimetidine 200 MG Oral Tablet SCD · 197505
  • Cimetidine 200 MG SCDC · 315678
  • Cimetidine Oral Tablet SCDF · 371515
  • Cimetidine Oral Product SCDG · 1151784
  • Cimetidine Pill SCDG · 1151785

Brand-Name Concepts

  • Cimetidine 200 MG [Tagamet] SBDC · 563491
  • Cimetidine Oral Tablet [Tagamet] SBDF · 94235
  • Tagamet Oral Product SBDG · 1177838
  • Tagamet Pill SBDG · 1177839
  • Tagamet BN · 152402

📦 FDA Products & Package NDCs

3 products · 12 package NDCs
12 package NDCs map to RxCUI 104062 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
52183-0223-30 3 BLISTER PACK in 1 BOX (52183-223-30) / 10 TABLET in 1 BLI... TAGAMET Prestige Brands Holdings, Inc. 2023-02-01
63029-0222-01 1 BLISTER PACK in 1 BOX (63029-222-01) / 30 TABLET in 1 BLI... Tagamet Medtech Products Inc. 2012-06-01
63029-0222-02 1 BLISTER PACK in 1 BOX (63029-222-02) / 6 TABLET in 1 BLIS... Tagamet Medtech Products Inc. 2012-06-01
63029-0222-03 1 BLISTER PACK in 1 BOX (63029-222-03) / 50 TABLET in 1 BLI... Tagamet Medtech Products Inc. 2012-06-01
63029-0222-04 4 BLISTER PACK in 1 BOX (63029-222-04) / 10 TABLET in 1 BLI... Tagamet Medtech Products Inc. 2019-06-01
63029-0222-05 4 BLISTER PACK in 1 BOX (63029-222-05) / 9 TABLET in 1 BLIS... Tagamet Medtech Products Inc. 2019-06-01
63029-0222-06 7 BLISTER PACK in 1 BOX (63029-222-06) / 10 TABLET in 1 BLI... Tagamet Medtech Products Inc. 2012-06-01
63029-0222-09 1 BOTTLE in 1 CARTON (63029-222-09) / 90 TABLET in 1 BOTTLE Tagamet Medtech Products Inc. 2012-06-01
63029-0222-11 1 BOTTLE in 1 CARTON (63029-222-11) / 100 TABLET in 1 BOTTL... Tagamet Medtech Products Inc. 2012-06-01
63029-0222-12 2 BLISTER PACK in 1 BOX (63029-222-12) / 6 TABLET in 1 BLIS... Tagamet Medtech Products Inc. 2012-06-01
63029-0222-70 1 BOTTLE in 1 CARTON (63029-222-70) / 70 TABLET in 1 BOTTLE Tagamet Medtech Products Inc. 2012-06-01
63029-0223-30 3 BLISTER PACK in 1 BOX (63029-223-30) / 10 TABLET in 1 BLI... Tagamet Medtech Products Inc. 2023-02-01
Observed labelers: Medtech Products Inc. (11) · Prestige Brands Holdings, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.